Stay updated on Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Sign up to get notified when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.

Latest updates to the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check17 days agoChange DetectedA notice about the NIH website transition was added, directing visitors to updates and FAQs and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.6%

- Check24 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check31 days agoChange DetectedThe footer’s ClinicalTrials.gov revision marker changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the prior v3.6.6. This indicates an update to the record metadata rather than substantive changes to the study content.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry, v3.6.6, was added to the record's history. The prior v3.6.5 entry was removed in this update.SummaryDifference0.1%

Stay in the know with updates to Phase I Dose Escalation Clinical Trial S64315 with Venetoclax
Enter your email address, and we'll notify you when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.